Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
772 000 KRW
0.26%
Market Closed
Updated:
Apr 29, 2024
Income Statement
Earnings Waterfall
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
|
Revenue
|
3.7T
KRW
|
|
Cost of Revenue
|
-1.9T
KRW
|
|
Gross Profit
|
1.8T
KRW
|
|
Operating Expenses
|
-689.1B
KRW
|
|
Operating Income
|
1.1T
KRW
|
|
Other Expenses
|
-256B
KRW
|
|
Net Income
|
857.7B
KRW
|
Income Statement
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
Currency: KRW
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||
| Revenue |
294 622
N/A
|
313 518
+6%
|
329 198
+5%
|
403 868
+23%
|
464 629
+15%
|
488 016
+5%
|
550 229
+13%
|
523 842
-5%
|
535 806
+2%
|
530 135
-1%
|
482 787
-9%
|
566 539
+17%
|
701 592
+24%
|
783 424
+12%
|
1 013 033
+29%
|
1 102 797
+9%
|
1 164 777
+6%
|
1 218 377
+5%
|
1 322 849
+9%
|
1 499 000
+13%
|
1 568 007
+5%
|
1 818 513
+16%
|
2 057 774
+13%
|
2 480 082
+21%
|
3 001 295
+21%
|
3 210 913
+7%
|
3 425 675
+7%
|
3 586 607
+5%
|
3 694 589
+3%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||
| Cost of Revenue |
(268 088)
|
(267 036)
|
(286 392)
|
(325 904)
|
(332 829)
|
(348 693)
|
(374 291)
|
(351 333)
|
(390 646)
|
(410 600)
|
(394 739)
|
(463 402)
|
(509 584)
|
(503 956)
|
(639 035)
|
(690 902)
|
(748 701)
|
(782 019)
|
(781 146)
|
(829 252)
|
(841 556)
|
(969 680)
|
(1 132 085)
|
(1 282 962)
|
(1 532 847)
|
(1 629 655)
|
(1 705 516)
|
(1 850 808)
|
(1 891 824)
|
|
| Gross Profit |
26 534
N/A
|
46 482
+75%
|
42 806
-8%
|
77 964
+82%
|
131 800
+69%
|
139 324
+6%
|
175 939
+26%
|
172 510
-2%
|
145 160
-16%
|
119 536
-18%
|
88 048
-26%
|
103 137
+17%
|
192 007
+86%
|
279 468
+46%
|
373 999
+34%
|
411 896
+10%
|
416 076
+1%
|
436 358
+5%
|
541 703
+24%
|
669 748
+24%
|
726 451
+8%
|
848 833
+17%
|
925 689
+9%
|
1 197 120
+29%
|
1 468 448
+23%
|
1 581 259
+8%
|
1 720 159
+9%
|
1 735 799
+1%
|
1 802 765
+4%
|
|
| Operating Income | ||||||||||||||||||||||||||||||
| Operating Expenses |
(56 957)
|
(59 838)
|
(61 453)
|
(63 280)
|
(65 821)
|
(66 754)
|
(71 168)
|
(77 752)
|
(89 481)
|
291 965
|
284 314
|
(106 854)
|
(100 266)
|
(101 758)
|
(99 755)
|
(104 727)
|
(123 290)
|
(131 850)
|
(151 537)
|
(168 705)
|
(189 142)
|
(209 403)
|
(283 345)
|
(397 447)
|
(484 821)
|
(582 307)
|
(637 441)
|
(659 291)
|
(689 085)
|
|
| Selling, General & Administrative |
(50 880)
|
(53 611)
|
(54 738)
|
(55 862)
|
(56 326)
|
(55 321)
|
(57 606)
|
(62 199)
|
(74 866)
|
(84 231)
|
(93 541)
|
(97 198)
|
(91 013)
|
(92 354)
|
(90 508)
|
(94 511)
|
(109 180)
|
(117 875)
|
(137 657)
|
(156 202)
|
(180 348)
|
(200 262)
|
(271 347)
|
(380 390)
|
(417 989)
|
(540 047)
|
(570 693)
|
(570 565)
|
(575 526)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1 091)
|
(5 106)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(45 884)
|
(16 726)
|
(38 071)
|
(59 186)
|
(81 588)
|
|
| Depreciation & Amortization |
(6 076)
|
(6 226)
|
(6 715)
|
(7 418)
|
(9 495)
|
(11 435)
|
(13 563)
|
(15 543)
|
(14 615)
|
(13 016)
|
(11 368)
|
(9 654)
|
(9 252)
|
(9 403)
|
(9 246)
|
(9 124)
|
(9 003)
|
(8 869)
|
(8 774)
|
(8 489)
|
(8 794)
|
(9 140)
|
(11 998)
|
(17 056)
|
(20 948)
|
(25 533)
|
(28 677)
|
(29 539)
|
(31 971)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
389 212
|
389 223
|
0
|
0
|
0
|
0
|
0
|
0
|
(5 106)
|
(5 106)
|
(4 014)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(30 423)
N/A
|
(13 354)
+56%
|
(18 645)
-40%
|
14 684
N/A
|
65 979
+349%
|
72 568
+10%
|
104 769
+44%
|
94 758
-10%
|
55 678
-41%
|
411 503
+639%
|
372 365
-10%
|
(3 715)
N/A
|
91 742
N/A
|
177 711
+94%
|
274 244
+54%
|
307 169
+12%
|
292 786
-5%
|
304 508
+4%
|
390 166
+28%
|
501 043
+28%
|
537 309
+7%
|
639 430
+19%
|
642 344
+0%
|
799 674
+24%
|
983 627
+23%
|
998 952
+2%
|
1 082 718
+8%
|
1 076 509
-1%
|
1 113 680
+3%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||
| Interest Income Expense |
(201 657)
|
(228 243)
|
(183 458)
|
(197 435)
|
(182 728)
|
(200 063)
|
(221 184)
|
(198 879)
|
(134 354)
|
(82 975)
|
(45 810)
|
10 393
|
61 798
|
61 050
|
51 928
|
50 028
|
(25 873)
|
(6 645)
|
15 775
|
30 805
|
32 302
|
49 069
|
21 642
|
(136 593)
|
(33 549)
|
(51 475)
|
(34 744)
|
83 466
|
1 451
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
0
|
389 214
|
0
|
0
|
389 224
|
(359)
|
(1 712)
|
(1 712)
|
(1 712)
|
(1 352)
|
0
|
0
|
0
|
0
|
2
|
64 421
|
65 079
|
65 106
|
65 104
|
772
|
5 185
|
5 159
|
|
| Gain/Loss on Disposition of Assets |
(1)
|
(4)
|
(4)
|
(5)
|
(45)
|
0
|
(64)
|
0
|
(612)
|
(1 008)
|
(1 098)
|
(1 099)
|
(806)
|
(474)
|
(391)
|
(1 640)
|
(1 841)
|
(1 777)
|
(1 750)
|
(3 483)
|
(7 466)
|
(7 465)
|
(8 225)
|
(6 906)
|
(2 588)
|
(2 704)
|
(1 957)
|
(1 064)
|
(3 866)
|
|
| Total Other Income |
1 180
|
1 106
|
979
|
987
|
798
|
900
|
931
|
873
|
(6 950)
|
(6 830)
|
(6 331)
|
(5 731)
|
3 060
|
3 279
|
3 168
|
2 872
|
2 272
|
1 908
|
1 070
|
413
|
(863)
|
(1 000)
|
(699)
|
(589)
|
(3 573)
|
(2 728)
|
(2 792)
|
(2 230)
|
3 563
|
|
| Pre-Tax Income |
(230 901)
N/A
|
(240 495)
-4%
|
(201 129)
+16%
|
(181 768)
+10%
|
(115 995)
+36%
|
(126 595)
-9%
|
(115 560)
+9%
|
(103 248)
+11%
|
302 976
N/A
|
320 688
+6%
|
319 126
0%
|
389 070
+22%
|
155 435
-60%
|
239 854
+54%
|
327 235
+36%
|
356 716
+9%
|
265 992
-25%
|
297 995
+12%
|
405 262
+36%
|
528 778
+30%
|
561 283
+6%
|
680 037
+21%
|
719 484
+6%
|
720 665
+0%
|
1 009 025
+40%
|
1 007 150
0%
|
1 043 997
+4%
|
1 161 866
+11%
|
1 119 987
-4%
|
|
| Net Income | ||||||||||||||||||||||||||||||
| Tax Provision |
54 078
|
56 301
|
44 870
|
37 915
|
19 023
|
16 036
|
7 569
|
(27)
|
(78 867)
|
(84 598)
|
(76 917)
|
(75 735)
|
47 469
|
38 152
|
16 202
|
(1 340)
|
(25 017)
|
(32 696)
|
(70 459)
|
(118 284)
|
(167 693)
|
(200 481)
|
(209 409)
|
(213 200)
|
(210 968)
|
(214 281)
|
(218 283)
|
(224 949)
|
(262 296)
|
|
| Income from Continuing Operations |
(176 823)
|
(184 194)
|
(156 259)
|
(143 853)
|
(96 972)
|
(110 558)
|
(107 989)
|
(103 273)
|
224 109
|
236 091
|
242 210
|
313 337
|
202 904
|
278 008
|
343 438
|
355 375
|
240 975
|
265 298
|
334 801
|
410 494
|
393 589
|
479 557
|
510 074
|
507 465
|
798 056
|
792 869
|
825 714
|
936 917
|
857 691
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(176 823)
N/A
|
(184 194)
-4%
|
(156 259)
+15%
|
(143 853)
+8%
|
(96 972)
+33%
|
(110 558)
-14%
|
(107 989)
+2%
|
(103 273)
+4%
|
224 109
N/A
|
236 091
+5%
|
242 210
+3%
|
313 337
+29%
|
202 904
-35%
|
278 008
+37%
|
343 438
+24%
|
355 375
+3%
|
240 975
-32%
|
265 298
+10%
|
334 801
+26%
|
410 494
+23%
|
393 589
-4%
|
479 557
+22%
|
510 074
+6%
|
507 465
-1%
|
798 056
+57%
|
792 869
-1%
|
825 714
+4%
|
936 917
+13%
|
857 691
-8%
|
|
| EPS (Diluted) |
-3 102.15
N/A
|
-2 790.81
+10%
|
-2 367.56
+15%
|
-2 179.59
+8%
|
-1 469.27
+33%
|
-1 675.12
-14%
|
-1 636.19
+2%
|
-1 564.74
+4%
|
3 395.59
N/A
|
3 577.13
+5%
|
3 669.84
+3%
|
4 747.53
+29%
|
3 074.3
-35%
|
4 212.24
+37%
|
5 203.6
+24%
|
5 384.46
+3%
|
3 651.13
-32%
|
4 019.66
+10%
|
5 000.89
+24%
|
6 131.5
+23%
|
5 879.01
-4%
|
7 163.09
+22%
|
7 219.15
+1%
|
7 129.92
-1%
|
11 431.89
+60%
|
11 139.86
-3%
|
11 601.34
+4%
|
13 163.75
+13%
|
12 050.63
-8%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
